Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 41 Records) |
| Query Trace: Myelodysplastic Syndromes and RUNX1[original query] |
|---|
| Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Sep . Della Porta Matteo G, Gallì Anna, Bacigalupo Andrea, Zibellini Silvia, Bernardi Massimo, Rizzo Ettore, Allione Bernardino, van Lint Maria Teresa, Pioltelli Pietro, Marenco Paola, Bosi Alberto, Voso Maria Teresa, Sica Simona, Cuzzola Mariella, Angelucci Emanuele, Rossi Marianna, Ubezio Marta, Malovini Alberto, Limongelli Ivan, Ferretti Virginia V, Spinelli Orietta, Tresoldi Cristina, Pozzi Sarah, Luchetti Silvia, Pezzetti Laura, Catricalà Silvia, Milanesi Chiara, Riva Alberto, Bruno Benedetto, Ciceri Fabio, Bonifazi Francesca, Bellazzi Riccardo, Papaemmanuil Elli, Santoro Armando, Alessandrino Emilio P, Rambaldi Alessandro, Cazzola Mar |
| Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes. PloS one 2016 11 (10): e0164370. Abáigar María, Robledo Cristina, Benito Rocío, Ramos Fernando, Díez-Campelo María, Hermosín Lourdes, Sánchez-Del-Real Javier, Alonso Jose M, Cuello Rebeca, Megido Marta, Rodríguez Juan N, Martín-Núñez Guillermo, Aguilar Carlos, Vargas Manuel, Martín Ana A, García Juan L, Kohlmann Alexander, Del Cañizo M Consuelo, Hernández-Rivas Jesús |
| Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R. American journal of hematology 2017 Sep . Tefferi Ayalew, Lasho Terra L, Patnaik Mrinal M, Saeed Lyla, Mudireddy Mythri, Idossa Dame, Finke Christy, Ketterling Rhett P, Pardanani Animesh, Gangat Nasee |
| Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia. American journal of hematology 2017 Mar . Patnaik Mrinal M, Barraco Daniela, Lasho Terra L, Finke Christy M, Reichard Kaaren, Hoversten Katherine P, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
| Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model. American journal of hematology 2018 Feb . Gangat Naseema, Mudireddy Mythri, Lasho Terra L, Finke Christy M, Nicolosi Maura, Szuber Natasha, Patnaik Mrinal M, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
| [Mutation analysis of 77 patients with normal-karyotype myelodysplastic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 Sep 36 (9): 857-861. Qin Wei, Chen Meiyu, Cai Xiaohui, Chao Hongying, Liu Jie, Jiang Naike, Zhou Min, Lu Xuzhang, Chen Suning, Zhang Ri, He Chuan, Wang Qi |
| Co-occurrence of RUNX1 and ASXL1 mutations underlie poor response and outcome for MDS patients treated with HMAs. American journal of translational research 2019 7 11 (6): 3651-3658. Wu Ping, Weng Jianyu, Li Minming, Lu Zesheng, Deng Chengxin, Sun Qihui, Xu Ruohao, Geng Suxia, Du X |
| Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes. Leukemia 2019 Feb . Follo Matilde Y, Pellagatti Andrea, Armstrong Richard N, Ratti Stefano, Mongiorgi Sara, De Fanti Sara, Bochicchio Maria Teresa, Russo Domenico, Gobbi Marco, Miglino Maurizio, Parisi Sarah, Martinelli Giovanni, Cavo Michele, Luiselli Donata, McCubrey James A, Suh Pann-Ghill, Manzoli Lucia, Boultwood Jacqueline, Finelli Carlo, Cocco Luc |
| Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes. Cancer science 2019 Dec . Jiang Lingxu, Luo Yingwan, Zhu Shuanghong, Wang Lu, Ma Liya, Zhang Hua, Shen Chuying, Yang Wenli, Ren Yanling, Zhou Xinping, Mei Chen, Ye Li, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis.
Blood advances 2019 Nov 3 (22): 3579-3589. McGraw Kathy L, Cheng Chia-Ho, Chen Y Ann, Hou Hsin-An, Nilsson Björn, Genovese Giulio, Cluzeau Thomas, Pellagatti Andrea, Przychodzen Bartlomiej P, Mallo Mar, Arenillas Leonor, Mohamedali Azim, Adès Lionel, Sallman David A, Padron Eric, Sokol Lubomir, Moreilhon Chimene, Raynaud Sophie, Tien Hwei-Fang, Boultwood Jacqueline, Ebert Benjamin L, Sole Francesc, Fenaux Pierre, Mufti Ghulam J, Maciejewski Jaroslaw P, Kanetsky Peter A, List Alan |
| Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern. Blood advances 2019 Oct 3 (20): 3111-3122. Berger Gerbrig, Gerritsen Mylene, Yi Guoqiang, Koorenhof-Scheele Theresia N, Kroeze Leonie I, Stevens-Kroef Marian, Yoshida Kenichi, Shiraishi Yuichi, van den Berg Eva, Schepers Hein, Huls Geert, Mulder André B, Ogawa Seishi, Martens Joost H A, Jansen Joop H, Vellenga E |
| [Analysis of mutations of 14 genes among 87 patients with myelodysplastic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 10 36 (10): 953-956. Zhou Xuyan, Jin He, Mu Qitian, Sheng Lixia, Lai Binbin, Zhu Huiling, Ouyang Guifa |
| A novel RUNX1 mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome. Aging clinical and experimental research 2020 9 33 (7): 1987-1992. Ferrari Silvia, Regazzo Daniela, Omenetto Elisabetta, Scaroni Carla, Semenzato Gianpietro, Fabris Fabrizio, Vianello Fabriz |
| Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation. Hematology (Amsterdam, Netherlands) 2020 6 25 (1): 211-218. Wang Kai, Zhou Feng, Cai Xiaohui, Chao Hongying, Zhang Ri, Chen Suni |
| [Features and clinical significance of gene mutations in patients with myelodysplastic syndromes with ring sideroblasts]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 6 41 (5): 379-386. Cai Y N, Xu Z F, Li B, Qin T J, Pan L J, Qu S Q, Hu N B, Liu D, Huang H J, Shi Z X, Zhang Y D, Xiao Z |
| [Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1977-1984. Zhao Wen-Shu, Zhang Yin-Tian, Jiang Qian-Li, Liu Qi-Fa, Dai M |
| Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms. Leukemia 2020 12 35 (8): 2371-2381. Todisco Gabriele, Creignou Maria, Gallì Anna, Guglielmelli Paola, Rumi Elisa, Roncador Marco, Rizzo Ettore, Nannya Yasuhito, Pietra Daniela, Elena Chiara, Bono Elisa, Molteni Elisabetta, Rosti Vittorio, Catricalá Silvia, Sarchi Martina, Dimitriou Marios, Ungerstedt Johanna, Vannucchi Alessandro Maria, Hellström-Lindberg Eva, Ogawa Seishi, Cazzola Mario, Malcovati Lu |
| Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine. Annals of hematology 2020 1 99 (3): 527-537. Martín Iván, Navarro Blanca, Serrano Alicia, Villamón Eva, Calabuig Marisa, Solano Carlos, Chaves Felipe Javier, Yagüe Nuria, Orts Maribel, Amat Paula, Fuentes Azahara, Seda Enrique, García Francisca, Hernández-Boluda Juan Carlos, Tormo M |
| The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm. International journal of laboratory hematology 2021 7 43 (6): 1501-1509. Ibrar Warda, Zhang Weiwei, Cox Jesse Lee, Cushman-Vokoun Allison, Fu Kai, Greiner Timothy C, Yuan |
| Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes. Cancer 2021 Jun . Kanagal-Shamanna Rashmi, Montalban-Bravo Guillermo, Sasaki Koji, Darbaniyan Faezeh, Jabbour Elias, Bueso-Ramos Carlos, Wei Yue, Chien Kelly, Kadia Tapan, Ravandi Farhad, Borthakur Gautam, Soltysiak Kelly A, Routbort Mark, Patel Keyur, Pierce Sherry, Medeiros L Jeffrey, Kantarjian Hagop M, Garcia-Manero Guiller |
| [Predisposition and progression of myelodysplastic syndromes]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2021 5 62 (4): 278-288. Makishima Hide |
| Mutations in chronic myelomonocytic leukemia and their prognostic relevance. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 4 23 (9): 1731-1742. Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu |
| [Characteristics and Clinical Significance of Gene Mutation in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2021 12 29 (6): 1864-1868. Zhao Fang, Wang Kai-Li, Qin Yu-Ting, Nilupar Tuerxun, Patiguli Abulizi, Jiang Ming, Hao Jian-Pi |
| Have we reached a molecular era in myelodysplastic syndromes? Hematology. American Society of Hematology. Education Program 2021 12 2021 (1): 418-427. Voso Maria Teresa, Gurnari Carme |
| Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. Scientific reports 2022 4 12 (1): 5925. Maurya Nehakumari, Mohanty Purvi, Dhangar Somprakash, Panchal Purvi, Jijina Farah, Mathan S Leo Prince, Shanmukhaiah Chandrakala, Madkaikar Manisha, Vundinti Babu R |
| New genetic variants of TET2 and ASXL1 identified by next generation sequencing and pyrosequencing in a patient with MDS-RS-MLD and secondary acute myeloid leukemia. Central-European journal of immunology 2022 2 46 (4): 524-530. Adamska Monika Ma?gorzata, Kowal-Wi?niewska Ewelina, Kiwerska Katarzyna, Ustaszewski Adam, Czerwi?ska-Rybak Joanna, Kandu?a Zuzanna, Wojtaszewska Marzena, Bara?ska Marta, Pruchniewski ?ukasz, Lewandowski Krzysztof, Jarmu?-Szymczak Ma?gorzata, Gil Lid |
| Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes. Hematological oncology 2022 11 . Lee Wan-Hsuan, Lin Chien-Chin, Wang Yu-Hung, Yao Chi-Yuan, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Hsu Cheng-An, Sun Hsun-I, Chuang Yi-Kuang, Hsu Chia-Lang, Tien Feng-Ming, Tsai Cheng-Hong, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
| IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons???60 years with myelodysplastic syndromes. Experimental hematology & oncology 2022 Oct 11 (1): 73. Wu Junying, Zhang Yudi, Qin Tiejun, Xu Zefeng, Qu Shiqiang, Pan Lijuan, Li Bing, Jia Yujiao, Li Chengwen, Wang Huijun, Gao Qingyan, Cai Wenyu, Gong Jingye, Zhao Songyang, Li Fuhui, Gale Robert Peter, Xiao Zhiji |
| U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
| High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes. Blood advances 2023 1 . Wang Yu-Hung, Lin Chien-Chin, Yao Chi-Yuan, Amaral Fabio, Yu Shan-Chi, Kao Chein-Jun, Shih Pin-Tsen, Hou Hsin-An, Chou Wen-Chien, Tien Hwei-Fa |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 05, 2023
- Content source: